Lactose-Based Direct Tableting Composition for Uniform Color
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional pharmaceutical tablet formulations face challenges in achieving homogeneous appearance and optimal performance, including flowability, ejection forces, and disintegration time, especially in multi-layered tablets and continuous manufacturing processes.
Innovation Solution
A direct tableting auxiliary composition combining lactose, water-soluble polyethylene glycol-polyvinyl alcohol graft copolymer as a binder, lubricants like magnesium stearate, and crosslinked polyvinylpyrrolidone, with a colorant, which is processed to create granules with high flowability and uniform color, eliminating the need for glidants and enabling continuous manufacturing.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Illumination intensity
If a colorant is physically mixed with a tableting aid to create colored tablets, then the tablet achieves visual appearance for patient compliance, but the powder composition shows a spotted blend with insufficient opacity and non-homogeneous appearance
Solution Approach 1:
The colorant is incorporated into the tableting aid composition during the granulation process before compression, allowing the color to be uniformly distributed throughout the matrix. This preliminary incorporation ensures homogeneous color distribution and sufficient opacity in the final tablet product.
Solution Approach 2:
The invention uses a composite composition containing lactose, polyethylene glycol-polyvinyl alcohol graft copolymer, colorant, and optionally crosslinked polyvinylpyrrolidone. This composite material approach allows the colorant to be uniformly integrated into the excipient matrix, achieving both homogeneous appearance and desired opacity.
2Ease of operation
If conventional excipient compositions are used to achieve good flowability, then the powder flows well during manufacturing, but the ejection forces during tableting are not optimal
Solution Approach 1:
The invention optimizes the composition parameters by incorporating specific ratios of lactose (70-90 wt%), polyethylene glycol-polyvinyl alcohol graft copolymer (5-20 wt%), and lubricant (0.1-5 wt%). This parameter optimization achieves a balance between good flowability during manufacturing and optimal ejection forces during tableting.
Solution Approach 2:
The composite excipient composition combines multiple materials with complementary properties: lactose provides bulk and flowability, the graft copolymer provides binding and disintegration control, and the lubricant minimizes ejection forces. This composite approach resolves the contradiction between flowability and ejection force.
3Strength
If a water-soluble binder is used to achieve high hardness, then the tablet hardness is improved, but the disintegration time increases
Solution Approach 1:
The invention uses a composite system where the polyethylene glycol-polyvinyl alcohol graft copolymer serves as a water-soluble binder providing high tablet hardness, while crosslinked polyvinylpyrrolidone (when present) acts as a disintegrant that promotes rapid water penetration and tablet breakdown. This composite approach allows simultaneous achievement of high hardness and fast disintegration.
Solution Approach 2:
The binder and disintegrant components are distributed throughout the tablet matrix, creating local zones with different functional properties. The binder provides structural integrity in dry state, while the disintegrant creates pathways for water penetration, enabling both high hardness and fast disintegration.
4Ease of operation
If glidants or flowability agents are added to improve powder flow, then the flowability increases, but the composition complexity and number of excipients increases
Solution Approach 1:
The lactose component in the composition serves multiple functions: it acts as a filler, provides bulk, and inherently provides good flowability without requiring additional glidants. The polyethylene glycol-polyvinyl alcohol graft copolymer also contributes to flow properties while providing binding and disintegration control. This multi-functionality reduces the total number of excipients needed.
Solution Approach 2:
The invention extracts or eliminates the need for separate glidant/flowability agent components by incorporating flow-enhancing properties directly into the main excipient composition (lactose and graft copolymer), thereby simplifying the formulation to contain fewer excipients.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition achieves high flowability, bulk density, and uniform color, enhancing tableting properties and disintegration time, suitable for various drug-containing tablets, including analgesics, with improved manufacturing efficiency and patient compliance through visual differentiation of active layers.
Implementation Method 1
a water-soluble polyethylene glycol-polyvinyl alcohol graft copolymer as binder
Implementation Method 2
the crosslinked polyvinylpyrrolidone may be Kollidon CL and/or Kollidon CL-SF and/or Kollidon CL-F... because of their swelling properties. They are thus predominantly used as disintegrants in tablets
Implementation Method 3
at least one lubricant... lubricants like magnesium stearate
Data Source
AI summary
The present invention relates to a direct tableting auxiliary composition based on lactose powder mixed intimately with a water-soluble polyethylene glycol-polyvinyl alcohol graft copolymeras binder, a lubricants, a colorant and optionally a crosslinked insoluble polyvinylpyrrolidone as tablet disintegrating agent.